High CRP Predicts Poor RCC-Specific Survival in Hemodialysis Patients
Study shows a 3.5 times increased risk of death from renal cancer in hemodialysis patients undergoing nephrectomy.
Study shows a 3.5 times increased risk of death from renal cancer in hemodialysis patients undergoing nephrectomy.
Researchers find a greater than 50% reduction in end-stage renal disease risk compared with radical nephrectomy.
Renal function is preserved better compared with radical nephrectomy even when tumors are larger than the traditional 4 cm cutoff.
Open procedures, preoperative dialysis, and higher ASA score were significant predictors of readmission after radical nephrectomy.
Following guidelines from the AUA and NCCN would miss many cases of disease recurrence following surgery, study suggests.
Risk is not eliminated if patients have risk factors for chronic kidney disease, such as hypertension and diabetes.
Increment in renal parenchymal volume occurs within days after a kidney is removed from a living donor.
Patients aged 75-79 who had localized tumors had worse cancer-specific survival with nonsurgical management than surgery.
The beneficial impact of this approach on renal function does not improve survival, however.
Partial nephrectomy may lead to better overall survival and fewer health problems after surgery in patients with kidney tumors.